SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lynch BM, Neilson HK, Friedenreich CM. Physical activity and breast cancer prevention. Recent Results Cancer Res 2011; 186: 1342.
  • 2
    World Cancer Research Fund and the American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.
  • 3
    Chen WY, Colditz GA. Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer. Nat Clin Pract Oncol 2007; 4: 41523.
  • 4
    McTiernan A, Thomas DB, Johnson LK, Roseman D. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J Natl Cancer Inst 1986; 77: 84954.
  • 5
    Lonning PE. Adjuvant endocrine treatment of early breast cancer. Hematol Oncol Clin North Am 2007; 21: 22338.
  • 6
    Adams SA, Matthews CE, Hebert JR, et al. Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2006; 15: 11708.
  • 7
    Bardia A, Hartmann LC, Vachon CM, et al. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med 2006; 166: 247883.
  • 8
    Bernstein L, Patel AV, Ursin G, et al. Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst 2005; 97: 16719.
  • 9
    Britton JA, Gammon MD, Schoenberg JB, et al. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol 2002; 156: 50716.
  • 10
    Chlebowski RT, Anderson GL, Lane DS, et al. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst 2007; 99: 1695705.
  • 11
    Dallal CM, Sullivan-Halley J, Ross RK, et al. Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med 2007; 167: 40815.
  • 12
    Dey S, Boffetta P, Mathews A, et al. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer 2009; 125: 166370.
  • 13
    Eliassen AH, Hankinson SE, Rosner B, et al. Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med 2010; 170: 175864.
  • 14
    Enger SM, Ross RK, Paganini-Hill A, et al. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 2000; 9: 6817.
  • 15
    George SM, Irwin ML, Matthews CE, et al. Beyond recreational physical activity: examining occupational and household activity, transportation activity, and sedentary behavior in relation to postmenopausal breast cancer risk. Am J Public Health 2010; 100: 228895.
  • 16
    McTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA 2003; 290: 13316.
  • 17
    Lee IM, Rexrode KM, Cook NR, et al. Physical activity and breast cancer risk: the Women's Health Study (United States). Cancer Causes Control 2001; 12: 13745.
  • 18
    Leitzmann MF, Moore SC, Peters TM, et al. Prospective study of physical activity and risk of postmenopausal breast cancer. Breast Cancer Res 2008; 10: R92.
  • 19
    Maruti SS, Willett WC, Feskanich D, et al. A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 2008; 100: 72837.
  • 20
    Peplonska B, Lissowska J, Hartman TJ, et al. Adulthood lifetime physical activity and breast cancer. Epidemiology 2008; 19: 22636.
  • 21
    Phipps AI, Chlebowski RT, Prentice R, et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 45463.
  • 22
    Schmidt ME, Steindorf K, Mutschelknauss E, et al. Physical activity and postmenopausal breast cancer: effective periods in life and effect modification by different breast cancer characteristics. Cancer Epidemiol Biomarkers Prev 2008; 17: 340210.
  • 23
    Suzuki R, Iwasaki M, Kasuga Y, et al. Leisure-time physical activity and breast cancer risk by hormone receptor status: effective life periods and exercise intensity. Cancer Causes Control 2010; 21: 178798.
  • 24
    Peters TM, Schatzkin A, Gierach GL, et al. Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 2009; 18: 28996.
  • 25
    Lahmann PH, Friedenreich C, Schuit AJ, et al. Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007; 16: 3642.
  • 26
    Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 111324.
  • 27
    Layfield LJ, Gupta D, Mooney EE. Assessment of tissue estrogen and progesterone receptor levels: a survey of current practice, techniques, and quantitation methods. Breast J 2000; 6: 18996.
  • 28
    Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatibility of the EPIC-norfolk physical activity questionnaire. Int J Epidemiol 2002; 31: 16874.
  • 29
    Cust AE, Smith BJ, Chau J, et al. Validity and repeatability of the EPIC physical activity questionnaire: a validation study using accelerometers as an objective measure. Int J Behav Nutr Phys Act 2008; 5: 33.
  • 30
    The Interact Consortium. Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol 2011; 27: 1525.
  • 31
    Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498504.
  • 32
    Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003; 6: 40713.
  • 33
    Friedenreich C, Norat T, Steindorf K, et al. Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006; 15: 2398407.
  • 34
    Kleinbaum DG, Klein M. Logistic regression: a self-learning text. New York: Springer-Verlag, Springer, 2002.
  • 35
    Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995; 51: 52432.
  • 36
    Monninkhof EM, Elias SG, Vlems FA, et al. Physical activity and breast cancer, a systematic review of current evidence. Epidemiology 2007; 18: 13757.
  • 37
    Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol 2007; 106: 2430.
  • 38
    James RE, Lukanova A, Dossus L, et al. Postmenopausal serum sex steroids and risk of hormone receptor-positive and −negative breast cancer: a nested case-control study. Cancer Prev Res (Phila) 2011; 4: 162635.
  • 39
    McTiernan A, Tworoger SS, Ulrich CM, et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 2004; 64: 29238.
  • 40
    Liedtke S, Schmidt ME, Becker S, et al. Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI? Cancer Causes Control 2011; 22: 819.
  • 41
    Bertone-Johnson ER, Tworoger SS, Hankinson SE. Recreational physical activity and steroid hormone levels in postmenopausal women. Am J Epidemiol 2009; 170: 1095104.
  • 42
    Dietel M, Lewis MA, Shapiro S. Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review. Hum Reprod 2005; 20: 205260.
  • 43
    Bernstein L, Ross RK, Lobo RA, et al. The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer 1987; 55: 6815.
  • 44
    Friedenreich CM. Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 2011; 188: 12539.
  • 45
    Carnevale RP, Proietti CJ, Salatino M, et al. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol 2007; 21: 133558.
  • 46
    Fazzari A, Catalano MG, Comba A, et al. The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG). Mol Cell Endocrinol 2001; 172: 316.